List of works - Fabio Nascimbeni

A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?

scientific article published on 05 December 2018

Alcohol and Steatosis: The Japanese Paradox

scientific article published on 19 May 2016

Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

scientific article published on 30 August 2018

Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology

scientific article

Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms

scientific article published on April 2014

Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis

scientific article published on February 2017

Clinical relevance of liver histopathology and different histological classifications of NASH in adults

scientific article published on 11 December 2017

Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent?

scientific article published on 14 May 2015

Drugs and acute porphyrias: reasons for a hazardous relationship.

scientific article

Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease

scientific article published on 20 October 2016

Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV

scientific article

From NAFLD in clinical practice to answers from guidelines ⬇️

scientific article published on June 7, 2013

Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis

scientific article published on 01 September 2012

Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?

scientific article published on 2 November 2017

Hypothyroidism and nonalcoholic fatty liver disease - a chance association?

scientific article published on 26 October 2018

Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: chance tetrad or association by necessity?

scientific article published in November 2013

Is it time to include non-alcoholic fatty liver disease in the current risk scores for atrial fibrillation?

scientific article published on 15 March 2018

Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease

scientific article published on 18 August 2020

NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.

scientific article

NAFLD, Hepatotropic Viruses, and Cardiometabolic Risk.

scientific article published on 13 January 2017

Non-alcoholic fatty liver disease: diagnosis and investigation.

scientific article published on 14 July 2014

Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm?

scientific article

Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.

scientific article published on 14 December 2015

Nonalcoholic fatty liver disease: Evolving paradigms.

scientific article published on September 2017

Nonalcoholic steatohepatitis heralding olmesartan-induced sprue-like enteropathy

scientific article

Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen

scientific article

Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity?

scientific article published on 02 January 2019

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease

scientific article published on 29 September 2014

Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease

article

Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications

scientific article

Significant variations in elastometry measurements made within short-term in patients with chronic liver diseases

scientific article published on 30 July 2014

Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes

scientific article published on 03 March 2019

Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease

scientific article published on 18 March 2016

Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: a clue to telomere involvement.

scientific article

Telomere shortening: An innocent bystander at the crossroad of NASH with ageing and cardiometabolic risk?

scientific article published on 01 October 2018

The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans

scientific article published on 26 February 2016

The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candi

scientific article published on 19 January 2016

The time has come to look for metabolic-dysfunction associated fatty liver disease in adult patients with type 1 gaucher disease

scientific article published on 22 October 2020

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight

scientific article

Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases

scientific article published on 13 April 2017

List of works by Fabio Nascimbeni

A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?

Alcohol and Steatosis: The Japanese Paradox

Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology

Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms

Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis

Clinical relevance of liver histopathology and different histological classifications of NASH in adults

Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent?

Drugs and acute porphyrias: reasons for a hazardous relationship.

Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease

Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV

From NAFLD in clinical practice to answers from guidelines ⬇️

Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis

Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?

Hypothyroidism and nonalcoholic fatty liver disease - a chance association?

Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: chance tetrad or association by necessity?

Is it time to include non-alcoholic fatty liver disease in the current risk scores for atrial fibrillation?

Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease

NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.

NAFLD, Hepatotropic Viruses, and Cardiometabolic Risk.

Non-alcoholic fatty liver disease: diagnosis and investigation.

Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm?

Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.

Nonalcoholic fatty liver disease: Evolving paradigms.

Nonalcoholic steatohepatitis heralding olmesartan-induced sprue-like enteropathy

Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen

Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity?

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease

Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease

Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications

Significant variations in elastometry measurements made within short-term in patients with chronic liver diseases

Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes

Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease

Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: a clue to telomere involvement.

Telomere shortening: An innocent bystander at the crossroad of NASH with ageing and cardiometabolic risk?

The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans

The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candi

The time has come to look for metabolic-dysfunction associated fatty liver disease in adult patients with type 1 gaucher disease

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight

Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases